GLP-1 և կրկնակիGIP/GLP-1 ընկալիչների ագոնիստներ
Ինկրետինային թերապիան ժամանակակից մետաբոլիկ բժշկության մեջ
Բեսթ Վեսթերն հյուրանոց, Իտալիայի փողոց 1, Երևան, Հայաստան, 0010
- 00
- 00
- 00
- 00
Join leading experts in endocrinology, obesity medicine, and clinical pharmacology for a deep dive into the evolving landscape of GLP-1 and Dual GIP/GLP-1 receptor agonists. This comprehensive two-day masterclass series will explore the past, present, and future of incretin-based therapies in the management of obesity, type 2 diabetes, and related comorbidities.
🎓 CME Accredited Event
SPEKAERS
Մեր խոսնակները
Prof. Bernhard Ludvik
Specialist in Internal Medicine, Endocrinology and Diabetology Head: 1st Department of Medicine with Diabetology, Endocrinology and Nephrology, Land Strasse Clinic Head: Karl Landsteiner Institute for Obesity and Metabolic Diseases.jpg)
Prof. Lorenzo M Donini
Sapienza University of Rome Experimental Medicine Department Medical Pathophysiology, Food Science and Endocrinology Section Food Science and Human Nutrition Research Unit.jpg)
Armen Mkrtchyan
Dietitian, Assotiate Professor of the Department of Hygiene and Ecology.YSMU.
Haykanush Hambardzumyan
Haykanush Hambardzumyan Endocrinologist, dietitian Wigmore clinic, Wigmore woman`s and children`s hospital. President of Armenian Association of Obesity Prevention
José Silva-Nunes,
Head of the Department of Endocrinology, Diabetes and Metabolism, Lisboa NOVA Medical School, Health and Technology Research Center President of the Portuguese Society for the Study of Obesity
Christian Alvarado Flores
Endocrinologist and Nutritionist. Master's degree in Obesity and Comorbidities. Medical Director of the Obesity Units at DROP by Sanità’s
Sarah Alam
Specialist Endocrinology at Canadian Specialist Hospital, Dubai Dubai, United Arab Emirates
Renata Markosyan
Endocrinologist, Head of the Department of Endocrinology Astkhik MC, Associated professor of YSMUՄիջոցառման ծրագիրը
1. GLP-1 and Dual GIP/GLP-1 Receptor Agonists: Past, Present, and Future Perspectives
Prof. Bernhard Ludvik
2. GLP-1 Receptor Agonists for the Treatment of Obesity: Global Data and Clinical Implications
José Silva-Nunes,
3. Dual GIP/GLP-1 Receptor Agonists in Obesity Care: Innovative Pharmacologic Strategies
Prof. Bernhard Ludvik
4. Gastrointestinal Adverse Events with GLP-1 Receptor Agonists: Clinical Recommendations
Christian Alvarado Flores
5. Rare Adverse Events in GLP-1 Therapy: A Clinical Approach
Renata Markosyan
6. GLP-1 Receptor Agonists in Managing Weight Regain After Bariatric Surgery
Christian Alvarado Flores
7. GLP-1 and dual GIP/GLP 1 receptor agonists: new insights and clinical managment in MAFLD
Sarah Alam
1. Nutritional Management for Patients on GLP-1 and Dual GIP/GLP-1 Receptor Agonists
Haykanush Hambardzumyan
Nutritional Management for Patients on GLP-1 and Dual GIP/GLP-1 Receptor Agonists
Armen Mkrtchyan
2. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes Mellitus
José Silva-Nunes,
3. Macro- and Micronutrient Deficiencies During GLP-1 Therapy and After Bariatric Surgery
Prof. Lorenzo M Donini
4. Dual GIP/GLP-1 Receptor Agonists: New Advances in Type 2 Diabetes Management
José Silva-Nunes,
6. Effects of GLP-1-Based Therapies on Body Composition
Prof. Lorenzo M Donini
Գրանցվել
Գրանցման արժեք
- Մասնակցության վճար €150.00x1 €150.00
- Մասնակցության վճար 66000.00 դրամ x1 66000.00 դրամ
Registration confirmation: Registration is not complete until payment is received and the Organiser issues a confirmation. The Organiser is not responsible for any issues arising from delayed or failed payment.
Կարող են մասնակցել՝
- Էնդոկրինոլոգներ
- Ընտանեկան բժիշկներ
- Բարիատրիկ վիրաբույժներ
- Կլինիկական դեղագործներ
- Սննդաբաններ և նուտրիցիոլոգներ
Have any questions?
պատասծան
dasdas